REVISION OF MEETING DATE AND PUBLIC ENGAGEMENT DETAILS: Joint Session of the Drug Safety and Risk Management Advisory Committee with the Anesthetic and Analgesic Drug Products Advisory Committee on May 5, 2025 – 05/05/2025 04/30/2025